Form 4 for ABT Abbott Laboratories
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-02 · accession 0001415889-23-007254 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-03 | 2023-05-02 | ABT | Wainer Andrea F | EVP | M - OptEx | $47.00 | +8,226 | 78.7K | +12% | +$386.6K |
| D | 2023-05-03 | 2023-05-02 | ABT | Wainer Andrea F | EVP | S - Sale+OE | $110.56 | -8,226 | 70.4K | -10% | -$909.5K |
| D | 2023-05-03 | 2023-05-02 | ABT | Wainer Andrea F | EVP | M - OptEx | $0.00 | -8,226 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2023-05-02 | M | A | 8,226 | $47.00 | 78,653 | D | — | — | |
| 2 | Common | Common shares without par value | 2023-05-02 | S | D | 8,226 | $110.56 | 70,427 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.5501 to $110.562, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Derivative | Option (right to buy) | 2023-05-02 | M | D | 8,226 | $0.00 | 0 | D | $47.00 · 2018-02-20 to 2025-02-19 | 8,226 Common Shares | (F2) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |